University of Wollongong

Research Online
Illawarra Health and Medical Research Institute

Faculty of Science, Medicine and Health

1-1-2017

WDR62 Regulates Early Neural and Glial Progenitor Specification of Human
Pluripotent Stem Cells
Abdullah J. Alshawaf
University of Melbourne

Ana Antonic
University of Melbourne

Efstratios Skafidas
University of Melbourne

Dominic Chi-Hung Ng
University of Queensland, d.ng1@uq.edu

Mirella Dottori
University of Melbourne, mdottori@uow.edu.au

Follow this and additional works at: https://ro.uow.edu.au/ihmri
Part of the Medicine and Health Sciences Commons

Recommended Citation
Alshawaf, Abdullah J.; Antonic, Ana; Skafidas, Efstratios; Ng, Dominic Chi-Hung; and Dottori, Mirella,
"WDR62 Regulates Early Neural and Glial Progenitor Specification of Human Pluripotent Stem Cells"
(2017). Illawarra Health and Medical Research Institute. 1153.
https://ro.uow.edu.au/ihmri/1153

Research Online is the open access institutional repository for the University of Wollongong. For further information
contact the UOW Library: research-pubs@uow.edu.au

WDR62 Regulates Early Neural and Glial Progenitor Specification of Human
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Abstract
Mutations in WD40-repeat protein 62 (WDR62) are commonly associated with primary microcephaly and
other developmental cortical malformations. We used human pluripotent stem cells (hPSC) to examine
WDR62 function during human neural differentiation and model early stages of human corticogenesis.
Neurospheres lacking WDR62 expression showed decreased expression of intermediate progenitor
marker, TBR2, and also glial marker, S100β. In contrast, inhibition of c-Jun N-terminal kinase (JNK)
signalling during hPSC neural differentiation induced upregulation of WDR62 with a corresponding
increase in neural and glial progenitor markers, PAX6 and EAAT1, respectively. These findings may signify
a role of WDR62 in specifying intermediate neural and glial progenitors during human pluripotent stem
cell differentiation.
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Mutations in WD40-repeat protein 62 (WDR62) are commonly associated with primary microcephaly and other developmental
cortical malformations. We used human pluripotent stem cells (hPSC) to examine WDR62 function during human neural
diﬀerentiation and model early stages of human corticogenesis. Neurospheres lacking WDR62 expression showed decreased
expression of intermediate progenitor marker, TBR2, and also glial marker, S100β. In contrast, inhibition of c-Jun N-terminal
kinase (JNK) signalling during hPSC neural diﬀerentiation induced upregulation of WDR62 with a corresponding increase in
neural and glial progenitor markers, PAX6 and EAAT1, respectively. These ﬁndings may signify a role of WDR62 in specifying
intermediate neural and glial progenitors during human pluripotent stem cell diﬀerentiation.

1. Introduction
WD40-repeat protein 62 (WDR62) mutations are common
genetic causes of human autosomal recessive primary microcephaly (MCPH), a neurodevelopmental disorder characterized by signiﬁcantly reduced cerebral cortex size at birth [1].
WDR62 mutations have also been implicated in several other
cortical malformations, suggesting pleiotropic functions during brain development [2, 3]. Wdr62 is a microtubuleassociated scaﬀold protein that is regulated by tiered c-Jun
N-terminal kinase (JNK) signalling modules [4, 5]. Wdr62
studies involving embryonic mouse brains and human cell
lines demonstrate its dynamic cell cycle-dependent spindle
pole localization and mitotic function [3, 6]. Knockdown of
Wdr62 expression in rat embryos disturbs cell division of
neural progenitors in the ventricular (VZ) and subventricular
(SVZ) zones, resulting in decreased proliferation and

premature diﬀerentiation [4]. Other studies examining
Wdr62 mutant mice attributed the reduction of neural progenitors to increased cell death resulting from cell cycle arrest
rather than altered diﬀerentiation of progenitors [7]. Taken
together, these studies support a role for WDR62 in neurogenesis during brain development although the precise role
and range of WDR62 functions remain unclear [2–4, 8, 9].
While studies in mice and immortalized cell lines have
greatly contributed to our understanding of WDR62’s role
in neurogenesis, it is important to further investigate its function within the context of human model systems. Human
pluripotent stem cells (hPSC) may be utilised to model processes associated with cortical development and related neurodevelopmental disorders in vitro [10, 11]. Accordingly,
here, we investigated the role of WDR62 in speciﬁcation to
neural and astrocyte progenitors via using an inducible
WDR62-depleted hPSC line and implementation of well-
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established protocols that generate cortical neural and glial
progenitors. Our ﬁndings show that downregulation of
WDR62 leads to reduction in intermediate neural and glial
progenitors derived from hPSC. Consistent with these ﬁndings, speciﬁc inhibition of JNK signalling in hPSC-derived
neural cultures enhanced expression of WDR62, giving rise
to an increase in neural and glial progenitors. Taken together,
these ﬁndings suggest that WDR62 is required for speciﬁcation of early neural and glial progenitors and a role for JNK
signalling in negatively regulating WDR62 in hPSC.

2. Materials and Methods
2.1. Maintenance of hPSC and Generation of shRNA
Knockdown Lines. This project is approved by the University
of Melbourne Human Ethics committee (number 1545384).
The H9 (WA-09, WiCell) cell line was a cultured feeder free
on vitronectin-coated plates using MTeSR-1 deﬁned media
according to the manufacturer’s instructions (Stem Cell
Technologies) and maintained at 37°C 5% CO2. Colonies
were mechanically dissected every 7 days and transferred
to freshly coated plates. Cell culture media were changed
every day.
shRNA knockdown was performed using SMARTchoice
inducible lentiviral small hairpin RNA (shRNA) targeting
human WDR62 (H15) (Dharmacon, catalog number:
VSH6376). H9 cells were plated on organ culture dish and
were transduced as per manufacturer’s instructions at MOI
of 0.5 and selected using 0.5 μg/mL puromycin. At day 7,
transduced hPSC (hPSC-H15) were temporarily treated with
1 μg/ml doxycycline (Dox) to induce expression of GFP and
further perform manual selection.
2.2. Neural and Glial Diﬀerentiation. Neural induction of H9
cells and/or WDR62 shRNA-transduced H9 cells were set
up as described by Denham and Dottori, with some slight
modiﬁcations [12]. hPSC and/or hPSC-H15 were mechanically dissected into pieces approximately 0.5 mm in width
and transferred to laminin-coated organ culture plates in
N2B27 medium containing 1 : 1 mix of neurobasal medium
with DMEM/F12 medium, supplemented with 1% insulin/
transferrin/selenium, 1% N2, 1% retinol-free B27, 0.3%
glucose, 25 U/ml penicillin, and 25 μg/ml streptomycin (Life
Technologies/Invitrogen). For diﬀerentiation to cortical
neurons, the small molecule inhibitor SB431542 (10 μM,
Tocris) and noggin (500 ng/ml, Peprotech) were added to
the media for the ﬁrst 7 days followed by the addition of
ﬁbroblast growth factor (FGF) (20 ng/ml, Peprotech) for
the remaining 7 days. Following 2 weeks of neural induction,
neural progenitors were mechanically harvested and cultured in suspension in neural basal media (NBM) supplemented with FGF (20 ng/ml, Peprotech) and epidermal
growth factor (EGF) (20 ng/ml, Peprotech) to promote neurosphere (NSP) formation [13]. To diﬀerentiate to glial cells,
pieces of neural induction colonies were plated onto
ﬁbronectin-coated organ culture plates containing NBM supplemented with FGF (20 ng/ml, Peprotech), EGF (20 ng/ml,
Peprotech), and PDGF-AA (20 ng/ml, Peprotech) for one
week followed by an additional week without supplements.
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shRNA-transduced hPSC cells were constantly treated with
0.5 μg/mL puromycin. Dox treatment commenced from the
beginning of the induction with no Dox controls set up in
parallel. Media change was performed every second day. At
the end of the experiment, samples were either ﬁxed and prepared for immunostaining or processed for real-time quantitative PCR (Q-PCR) expression analyses.
2.3. Immunostaining. Cell monolayers and NSPs were ﬁxed
in 4% PFA for 20 minutes at 4°C and then washed brieﬂy
in PBS. NSPs were embedded in Tissue-Tek OCT compound
(Labtek) and cut at 15 μm on a cryostat, and sections were
placed on superfrost slides. After washing in PBS, sections
or culture dishes were permeabilized with 0.1% Triton-X100 in PBS (PBT) for 5 minutes and then blocked in 10% fetal
calf serum in PBT for 60 minutes at room temperature. Samples were then incubated with primary antibody (diluted in
the block buﬀer) overnight at 4°C. The following primary
antibodies were used: goat anti-SOX2 (1 : 200, R&D Systems),
mouse anti-PAX6 (1 : 80, DSHB), rabbit anti-TBR2 (1 : 1000,
Chemicon), mouse anti-TUJ1 (1 : 1000, Millipore), rabbit
anti-KI67 (1 : 600, Abcam), and mouse anti-S100β (1 : 500,
Sigma). Following three 5 minute washes in PBT, ALEXA
Fluor secondary antibodies (Life Technologies/Invitrogen)
(1 : 1000 diluted in the block buﬀer) were applied for 1 hour
at room temperature. All samples were counterstained with
49,6-diamidino-2-phenylindole (DAPI; 1 μg/ml, SigmaAldrich). Samples were then mounted onto glass slides with
5 μl of moviol aqueous mountant followed by viewing and
image capturing under Zeiss Axio Observer z1 ﬂuorescence
microscope using ZEN imaging software.
2.4. Gene Expression Analysis. Cells were harvested and processed for total RNA extraction using PureLink RNA Mini Kit
(Life Technologies). Quality of RNA was examined on NanoDrop 2000 Spectrophotometer (Thermo Scientiﬁc) with
A260/280 ratio ranging from 1.95 to 2.05. Up to 2 μg of RNA
was used to synthesize ﬁrst-strand cDNA using SensiFAST
cDNA Synthesis Kit (Bioline). Q-PCR reaction and data collection was performed on ViiA7 Real-Time PCR System (Life
Technologies) using Universal Master Mix (Applied Biosystems), and raw data were exported to Microsoft Excel for further analysis. Cycling parameters were as follows: 50°C for 2
minutes, 95°C for 10 minutes to activate DNA polymerase,
then 40 cycles of 95°C for 15 seconds, and 60°C for 1 minute.
ΔCT values were obtained by normalization to the mean of
three internal reference genes GAPDH, HMBS, and ELF1.
Next, ΔΔCT values were obtained by normalization to ΔCT
values of appropriate control samples. Relative gene expression values (fold change) were then calculated using the
2−ΔΔCT method [14]. Statistical signiﬁcance tests were performed using unpaired t-test and one-way ANOVA with
post hoc Bonferroni multiple comparisons.
2.5. NSP Size Measurements. To compare the size of hPSCH15-derived NSPs treated with Dox versus no Dox treatment, for each independent experiment (n = 4), brightﬁeld
images were randomly taken for at least 3 NSPs for each condition using Zeiss Axio Observer z1 ﬂuorescence microscope
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and ZEN imaging software. All images were taken at a consistent magniﬁcation for each experiment. ImageJ software was
used to estimate the largest diameter of each NSP, brieﬂy, by
manually drawing a straight line across the centre of the NSP
and the length of which was documented in μm. Statistical
signiﬁcance tests were performed using Mann–Whitney test.
2.6. Quantiﬁcation of S100β. WDR62 shRNA-transduced
hPSC underwent glial diﬀerentiation for 2 weeks and then
processed for immunoﬂuorescence staining of S100β as
described above. S100β-positive neurons in Dox treated and
no Dox treatment were analysed from at least 3 replicates.
Images for analysis were taken using 20x objective Zeiss Axio
Observer z1 ﬂuorescence microscope and ZEN imaging software. ImageJ software was used to quantify integrated density
of S100β staining within images for each replicate. The
results from Dox treated were compared to the normalized
results obtained from the no Dox group (set at 100%). Twotailed t-test was used to determine statistical signiﬁcance.
2.7. JNK Inhibition. JNK inhibitor was obtained from EMD
Millipore (catalog number: 420135), reconstituted in
dimethyl sulfoxide (DMSO) to 50 mM, and used at 50 μM.
H9 neural inductions were treated with JNK inhibitor from
day 0 of neural induction, and DMSO-treated control was
always set up in parallel. The experiment was conducted at
least three times. Cultures were harvested for Q-PCR analyses. Two-tailed t-test was used to determine statistical
signiﬁcance.

3. Results
3.1. WDR62 Is Expressed during Neural Induction Coinciding
with Early Neural Progenitors. To determine whether
WDR62 was upregulated during hPSC neural diﬀerentiation,
endogenous WDR62 expression was measured by Q-PCR
during stages of hPSC neural induction and diﬀerentiation
to neural and glial progenitors. The protocol used for neural
induction was the dual SMAD inhibition which involves
treating hPSC with inhibitors of the bone morphogenic protein and/or activin/nodal signalling pathways, noggin, and
SB431542, respectively, for 7 days followed by FGF for
another 7 days [15]. hPSC-derived progenitors were organize
in a rosette-like morphology expressing early telencephalic
progenitor marker PAX6 and intermediate progenitor
marker TBR2 (Figure 1). Neural progenitors are mechanically harvested and cultured in a suspension supplemented
with FGF and EGF for one week to form NSP aggregates.
NSPs cultured for one week consisted of mixed populations
of early intermediate and postmitotic neural and glial progenitors as indicated by expression of SOX2, PAX6, TBR2,
TUJ1, and S100β (Figure 1) [16, 17].
WDR62 expression was signiﬁcantly upregulated during
early stages of neural induction at day 7 (ANOVA,
P < 0 05, n = 5), which co-coincided with the onset of SOX2
and PAX6 expression (Figure 1(f)). WDR62 expression was
then signiﬁcantly reduced at the end of neural induction
(ANOVA, P < 5 0E − 03, n = 5) and also at the NSP stage
(ANOVA, P < 5 0E − 03, n = 5), which corresponded with
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an increase in expression of TBR2, TUJ1, EAAT1, and
S100β (Figure 1(f)). These ﬁndings suggest that WDR62 is
upregulated at the onset of hPSC neural induction, correlating with speciﬁcation of early neural progenitors.
3.2. Inducible Knockdown of WDR62 Expression during hPSC
Neural Induction. Given that WDR62 expression was upregulated at the early stages of neural induction, we explored
the impact of reduced WDR62 expression on hPSC neural
diﬀerentiation. For these analyses, hPSC were transduced
with WDR62 Dox-inducible lentiviral shRNA construct
(H15), which coexpress GFP. hPSC-H15 underwent neural
induction and diﬀerentiation using the dual SMAD inhibition protocol, as previously described, either in the presence
or absence of doxycycline (Dox/no Dox) (Figure 2). Treatment with Dox eﬃciently induced universal GFP expression in hPSC-H15-derived neural progenitors at the neural
induction stage, and GFP expression was maintained in 1week-old NSPs (Figure 2(b)). At the neural induction stage,
Dox-treated hPSC-H15 exhibited signiﬁcant mean reduction
(40%) in the expression of WDR62 relative to no Dox treatment (two-tailed t-test, P = 0 04, n = 4) (Figure 2(c)). Similarly at the NSP stage, WDR62 expression was reduced by
more than 70% in Dox-treated hPSC-H15-derived NSPs
compared to no Dox-treated NSPs (two-tailed t-test,
P = 7 3E − 6, n = 6) (Figure 2(c)). Although NSPs were generated in conditions with reduced WDR62 expression, their
size was signiﬁcantly smaller than the no Dox-treated controls (Mann–Whitney U test, P = 0 03) (Figure 2(d), Supplemental Table 1 available online at https://doi.org/10.1155/
2017/7848932). Overall, these results conﬁrm that the Dox
induction of WDR62 shRNA was eﬀective at reducing
endogenous WDR62 expression in hPSC-derived neural
stem cells and progenitors.
3.3. Downregulation of WDR62 during Neural Diﬀerentiation
Reduced Early Neural and Glial Progenitors. To investigate
further the observed eﬀect of WDR62 depletion resulting in
NSP size reduction, we analysed the expression of neural
stem cell and progenitor markers in Dox-treated hPSC-H15
cultures by Q-PCR at both the neural induction and NSP
stages of diﬀerentiation. We did not observe signiﬁcant
changes in gene expression of proliferation marker KI67 or
cell death marker caspase 3 (CASP3) with reduced WDR62
expression (Figures 3(a) and 3(b)). Expression of mitotically
active neural progenitor markers, SOX2 and PAX6, was also
not signiﬁcantly changed (Figures 3(a) and 3(b)). In contrast,
expression of TBR2, marker of intermediate neural progenitors, and the glial marker S100β was both signiﬁcantly
reduced in neural induction cultures (two-tailed test,
P = 8 0E − 04 for TBR2 and P = 0 03 for S100β, n ≥ 3) and
NSPs (two-tailed t-test, P = 0 01 for TBR2 and P = 0 01 for
S100β, n ≥ 3) following Dox-induced WDR62 knockdown
(Figures 3(a) and 3(b)). Interestingly, reduced TBR2 and
WDR62 expression in NSPs corresponded with a trend
towards increased TUJ1 expression, a marker of postmitotic
neurons (Figure 3(b)). Taken together, these results suggest
a role of WDR62 in hPSC neural diﬀerentiation, particularly
in hPSC speciﬁcation to early neural and glial progenitors.
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Figure 1: Expression of WDR62 in hPSC-derived neural progenitors. (a) Schematic diagram outlining neural induction protocol for deriving
cortical neuronal progenitors. (b-c) DS neural induction protocol generates neural progenitors expressing early neural progenitor markers
SOX2 (b, green) and PAX6 (c, red) and intermediate progenitor marker TBR2 (c, green). DAPI stains of nuclei are also shown. Scale
bars = 50 μm. (d-e) hPSC-derived 1-week-old NSPs also express neuronal marker TUJ1 (d, red), proliferative marker KI67 (d, green), and
glial marker S100β (e, red). DAPI stains of nuclei are shown in (e). Scale bars = 75 μm. (f) Gene expression analyses of pluripotency
marker OCT4; neural progenitor markers SOX2, PAX6, and TBR2; neuronal marker TUJ; glial markers EAAT1 and S100β; and
proliferative marker KI67 and WDR62 across several time points of the neural induction protocol, including hPSC, day 7 NI, day 14 NI,
and 1-week NSPs (n ≥ 4 independent experiments for each time point, >3 NSPs per experiment). Data presented as means ± S.E.M. oneway ANOVA with a post hoc Bonferroni multiple comparison was used to assess signiﬁcance for each gene, comparing all pairs of time
points. ∗ P < 0 05; ∗∗ P < 5 0E − 03; ∗∗∗ P < 1 0E − 04; ∗∗∗∗ P < 1 0E − 05. NI: neural induction; NSPs: neurospheres.
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Figure 2: Eﬃcient knockdown of WDR62 expression in hPSC-derived neural progenitors. (a) Map of inducible lentiviral shRNA vector and
targeted sequence of WDR62. (b) GFP and corresponding brightﬁeld images of WDR62 shRNA-transduced hPSC-derived neural progenitors
with versus without Dox treatment at neural induction and NSP stages. (c) Gene expression analyses showing downregulation of WDR62
expression in WDR62 shRNA-transduced hPSC-derived neural progenitors treated with Dox versus no Dox treatment at neural induction
(P = 0 04) and NSP stages (P = 7 3E − 6) (n = 4 and n = 6 independent experiments, resp., >3 NSPs per experiment). Two-tailed t-test was
used to assess signiﬁcance. (d) Diameter measurements of WDR62 shRNA-transduced hPSC-derived NSPs treated with Dox versus no
Dox controls (n = 3 independent experiments, >3 NSPs per experiment). Mann–Whitney U test was used to assess signiﬁcance. ∗ P < 0 05;
∗∗∗∗
P < 5 0E − 05. NI: neural induction; NSPs: neurospheres; Dox: doxycycline.

3.4. WDR62 Is Required for Diﬀerentiation to Glial
Populations. To further determine whether reduced WDR62
expression impacted on the diﬀerentiation of hPSC to glial
progenitors, hPSC-H15 was diﬀerentiated to glia in both
Dox and no Dox treatment conditions. The glial diﬀerentiation protocol is similar to the neural induction protocol
described above; however after 14 days cells are passaged onto
ﬁbronectin substrate in media supplemented with FGF, EGF,
and PDGF-AA for one week followed by media without supplements for another week (Figure 4(a)). It was found that

Dox-treated glial diﬀerentiation cultures, which had reduced
WDR62 expression, resulted in a signiﬁcant decrease in the
number of S100β-positive cells compared to controls (twotailed t-test, P = 4 9E − 04, n = 3) (Figure 4). This ﬁnding further supports the requirement of WDR62 for early stages of
hPSC glial diﬀerentiation.
3.5. Inhibition of JNK Enhances the Expression of WDR62 and
PAX6. To further investigate the mechanisms underlying
WDR62 function, we examined the contribution of JNK
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Figure 3: WDR62 knockdown eﬀects hPSC speciﬁcation to neural and glial progenitors. (a) Q-PCR data suggest signiﬁcant reduction of
TBR2 (P = 8 0E − 04), S100β (P = 0 03), and CASP3 (P = 0 02) expression in Dox-treated WDR62 shRNA-transduced hPSC-derived
neural progenitors treated with Dox versus no treatment at day 14 neural induction (N ≥ 3 independent experiments). Two-tailed t-test
was used to assess signiﬁcance. (b) Similarly, Q-PCR data suggest signiﬁcant reduction of TBR2 (P = 0 01) and S100β (P = 0 01)
expression in Dox-treated versus no Dox treatment at the NSP stage (N ≥ 3 independent experiments, >3 NSPs per experiment). Twotailed t-test was used to assess signiﬁcance. ∗ P < 0 05; ∗∗∗∗ P < 5 0E − 05. NI: neural induction; NSPs: neurospheres; Dox: doxycycline.

activity as WDR62/JNK signalling interactions were previously shown to play a critical role in cortical development
[4, 18]. Thus, we attenuated JNK activity in our diﬀerentiation system with a kinase-speciﬁc chemical inhibitor (JNK
inhibitor VIII, 50 mM) at doses previously demonstrated to
attenuated WDR62/JNK signalling to downstream substrate
[6]. We then assessed the expression of WDR62 and candidate genes related to neural and glial diﬀerentiation, cell
death, and proliferation by Q-PCR. Our results indicate signiﬁcantly enhanced expression of WDR62 (two-tailed t-test,
P = 0 02, n = 3) following JNK inhibition, compared to
DMSO-treated control samples (Figure 5). This was accompanied by signiﬁcantly increased expression of PAX6 (twotailed t-test, P = 0 01, n = 3) and functional glial marker
EAAT1 (two-tailed t-test, P = 0 04, n = 3) (Figure 5). In addition, there was a trend towards increased S100β following
JNK inhibition. These ﬁndings are consistent with reports
of JNK being a negative regulator of WDR62 mitotic function
and expression and are consistent with the role of WDR62 in
neuro- and gliogenesis [6].

4. Discussion
This study is the ﬁrst to utilise hPSC-based modelling system to investigate the role of WDR62 in neurogenesis. We
show that WDR62 is expressed in hPSC-derived neural
progenitors with the highest expression occurring early in
neural induction coinciding with the onset of early neural progenitor markers SOX2 and PAX6. This is consistent with previous reports describing Wdr62 expression in precursors
undergoing mitosis in the VZ, SVZ, and cortical plate [4, 8].
Others have also reported expression of WDR62 in

postmitotic neurons [7]. Here, we show that knockdown of
WDR62 expression in hPSC-derived neural cultures resulted
in altered diﬀerentiation to early neural and glial progenitors
as indicated by the reduced expression of TBR2 and S100β.
Related to these ﬁndings, previous studies in Wdr62 mutant
mice demonstrated cortical defects whereby PAX6 and Tbr2
expression were signiﬁcantly reduced within the cortical
regions; however, there were no signiﬁcant diﬀerences in
Tbr2 expression speciﬁcally within the VZ regions [4, 7].
Accompanied with this depletion of neural progenitors, one
study observed reduced cell proliferation and increased premature neuronal diﬀerentiation while another study reported
mitotic delay and increased cell death [4, 7]. In contrast to these
ﬁndings, Jayaraman et al. found an increased ratio of TBR2+/
SOX2+ progenitors and increased Ki67+ PAX6− cells beyond
VZ and SVZs in embryonic day 14 Wdr62 null mice and
reduced overall cortical thickness with no evidence of
increased cell death. This led the authors to conclude that loss
of Wdr62 causes cell fate change speciﬁcally in switching from
PAX6 to Tbr2 progenitors with no cell death, resulting in
premature delamination of PAX6 progenitors from VZ [19].
In our studies, we did not observe any diﬀerences in markers
of cellular proliferation or cell death in WDR62 knockdown
hPSC cultures, although NSP size were smaller, suggesting that
only subpopulations of progenitors were aﬀected by the downregulation of WDR62. In light of these ﬁndings, we propose
that WDR62 is likely to play a critical role in the speciﬁcation
of early neural and glial progenitors.
During cortical development, PAX6 expressing radial
glial cells residing within the VZ undergo self-renewal and/
or diﬀerentiation to give rise to intermediate neural/glial progenitors, postmitotic cortical neurons, or glia [20–23].
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Figure 4: WDR62 knockdown eﬀects diﬀerentiation to astrocytes. (a) Schematic diagram outlining protocol for hPSC diﬀerentiation to
astrocytes. (b) GFP, brightﬁeld, and S100β immunostaining images of WDR62 shRNA-transduced hPSC-derived astrocytes with versus
without Dox treatment at the end of diﬀerentiation. DAPI stains of nuclei are shown. Scale bars = 50 μm. (c) Quantiﬁcation analyses of
S100β-positive cells suggesting signiﬁcantly decreased (P = 4 9E − 04) diﬀerentiation to astrocytes in Dox-treated group versus no Dox
treatment controls (n = 3 independent experiments). Two-tailed t-test was used to assess signiﬁcance. ∗∗∗ P < 5 0E − 04. Dox: doxycycline.

Intermediate neural progenitors are identiﬁed by the expression of Tbr2, which divide and diﬀerentiate within the SVZ to
produce more neurons [20–22, 24–26]. Similar to cortical
neurons, astrocytes are produced either directly from radial
glia or indirectly from more glial restricted intermediate progenitors within the SVZ [27, 28]. Towards the end of cortical
development, the majority of radial glial cells lose their identity to diﬀerentiate to astrocytes expressing S100β [27, 29,
30]. Given this knowledge, it may be that WDR62 plays a role
in transitioning hPSC-derived PAX6 neural precursors to
intermediate progenitors of neural and glial lineages. Similar
to radial glial cells, there may be hPSC-derived PAX6 precursor subpopulations that bypass the intermediate TBR2
progenitor stage and directly diﬀerentiate to postmitotic neurons, which may explain why there were no signiﬁcant
changes in TUJ1 expression in the WDR62 knockdown
NSPs. Alternatively, or in addition to, WDR62 may play a
role in self-renewal of intermediate neural/glial progenitors,
but not in self-renewal of PAX6 neural precursors. Further
in-depth studies of WDR62 expression and function are
needed to determine the underlying mechanisms of how
WDR62 regulates hPSC neural diﬀerentiation. Overall, the

ﬁndings from this study shed light on WDR62’s role in
human corticogenesis.
The WDR62 mitotic function has been linked to the
activity of JNK [6, 9]. It has been shown that WDR62 recruits
JNK1 to the spindle microtubules speciﬁcally during mitosis
and reciprocally JNK1 regulates WDR62 intercellular distribution. Speciﬁcally, JNK phosphorylation of WDR62 negatively regulates the association of WDR62 with the spindle
microtubules [6]. As a result of inhibiting JNK signalling, it
has been shown that the WDR62 microtubules association
was persistent irrespective of the cell cycle stage [6]. Our
results indicate that JNK activity is not required for
WDR62 function with regard to specifying neural and glial
progenitors derived from hPSC. In contrast, treatment with
JNK-speciﬁc inhibitor increased WDR62 expression in
hPSC-derived neural progenitors and this coincided with
enhanced expression of PAX6-positive cells and astrocyte
functional marker EAAT1. Thus, our ﬁndings indicate that
JNK activity may also negatively regulate the expression
levels of WDR62. Nevertheless, our studies in hPSC-derived
neural progenitors suggest that WDR62 expression is
required for the speciﬁcation of speciﬁc neural and glial

8

Stem Cells International

References

2.5

Fold change (2‒ΔΔCT)

2.0
⁎

⁎

⁎

1.5
⁎⁎
1.0

0.5

WDR62

KI67

CASP3

S100훽

EAAT1

TUJ1

TBR2

PAX6

SOX2

OCT4

0.0

DMSO-treated NI
JNK inhibitor-treated NI
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assess signiﬁcance. ∗ P < 0 05; ∗∗ P < 5 0E − 03.

lineages and this does not appear to require JNK signalling
activity, a ﬁnding that is contrary to rodent studies.

5. Conclusions
This study demonstrates the robustness of hPSC as a complementary modelling system investigating the developmental
roles of candidate genes implicated in major brain developmental disorders. Our ﬁndings show that downregulation
of WDR62 leads to reduction in intermediate neural and glial
progenitors derived from hPSC. Consistent with these ﬁndings, speciﬁc inhibition of JNK in hPSC-derived neural cultures enhanced the expression WDR62, giving rise to an
increase in neural and glial progenitors. Taken together,
these ﬁndings suggest that WDR62 is required for speciﬁcation of early hPSC-derived neural and glial progenitors.
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